Home > News > Mirus Bio Corporation Enters Into Agreement With Pfizer Inc.
January 9th, 2007
Mirus Bio Corporation Enters Into Agreement With Pfizer Inc.
Mirus Bio Corporation announced today it has entered into a two year, multimillion dollar agreement with Pfizer Inc. to investigate and optimize gene silencing methods in animal models. The studies will utilize Mirus Bio's nucleic acid delivery platforms to target and suppress the expression of genes of interest to Pfizer.
Harris & Harris Group Portfolio Company, HZO, Announces Partnerships with Dell and Motorola August 1st, 2015
Nanometrics Announces Upcoming Investor Events July 28th, 2015
Harris & Harris Group Portfolio Company, Bridgelux, Enters into Agreement to be Acquired by an Investment Group July 22nd, 2015
Harris & Harris Group Portfolio Company, OpGen, Gains $6 Million Investment From Merck GHI in Addition to New Acquisition July 16th, 2015
Quantum states in a nano-object manipulated using a mechanical system August 3rd, 2015
Nanoparticles used to breach mucus barrier in lungs: Proof-of-concept study conducted in mice a key step toward better treatments for lung diseases August 3rd, 2015
Promising Step Taken in Iran towards Treatment of Spinal Cord Injury August 3rd, 2015
Diagnosis of Salmonella Bacterium-Caused Food Poisoning by Biosensors August 3rd, 2015